SPL-5

N/A

Report date: 2022/11/14 14:30:09
NME

Base Information

Drug NameSPL-5
Drug Alias NameSPL-5
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMucin-5AC inhibitorsMucin-5B inhibitors
TargetsMucin-5ACMucin-5B
Therapy Area/IndicationsLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvstera Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesSplisense Ltd
Inactive CompaniesN/A
Active IndicationsLung Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A